These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34044125)
1. Apolipoprotein E isoform-dependent effects on the processing of Alzheimer's amyloid-β. Chai AB; Lam HHJ; Kockx M; Gelissen IC Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Sep; 1866(9):158980. PubMed ID: 34044125 [TBL] [Abstract][Full Text] [Related]
2. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
3. The interaction of amyloid-beta with ApoE. Carter DB Subcell Biochem; 2005; 38():255-72. PubMed ID: 15709483 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439 [TBL] [Abstract][Full Text] [Related]
6. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669 [TBL] [Abstract][Full Text] [Related]
7. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease. Aleshkov S; Abraham CR; Zannis VI Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639 [TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164 [TBL] [Abstract][Full Text] [Related]
9. Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease. Xia Z; Prescott EE; Urbanek A; Wareing HE; King MC; Olerinyova A; Dakin H; Leah T; Barnes KA; Matuszyk MM; Dimou E; Hidari E; Zhang YP; Lam JYL; Danial JSH; Strickland MR; Jiang H; Thornton P; Crowther DC; Ohtonen S; Gómez-Budia M; Bell SM; Ferraiuolo L; Mortiboys H; Higginbottom A; Wharton SB; Holtzman DM; Malm T; Ranasinghe RT; Klenerman D; De S Nat Commun; 2024 Jun; 15(1):4695. PubMed ID: 38824138 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging. Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682 [TBL] [Abstract][Full Text] [Related]
11. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease. Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894 [TBL] [Abstract][Full Text] [Related]
12. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Tokuda T; Calero M; Matsubara E; Vidal R; Kumar A; Permanne B; Zlokovic B; Smith JD; Ladu MJ; Rostagno A; Frangione B; Ghiso J Biochem J; 2000 Jun; 348 Pt 2(Pt 2):359-65. PubMed ID: 10816430 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease. Butterfield DA; Mattson MP Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology. Baum L; Chen L; Ng HK; Pang CP Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880 [TBL] [Abstract][Full Text] [Related]
15. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020 [TBL] [Abstract][Full Text] [Related]
16. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668 [TBL] [Abstract][Full Text] [Related]
17. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function. Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252 [TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287 [TBL] [Abstract][Full Text] [Related]
20. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]